Survival Without Adjuvant Therapy for Low-Risk Endometrial Cancer With Isolated Tumor Cells
This cohort study assesses overall survival without adjuvant therapy in patients with uterine factor–based low-risk endometrial cancer who had isolated tumor cells present in regional lymph nodes.
Authors
- Michiko Kodama (ORCID: https://orcid.org/0000-0003-4046-7572)
- Emmeline Friedman (ORCID: https://orcid.org/0000-0003-0934-1074)
- Yoshikazu Nagase (ORCID: https://orcid.org/0000-0003-0994-1600)
- Matthew W. Lee (ORCID: https://orcid.org/0009-0005-5776-2369)
- Jennifer A Yao
- Alexia J. Ouzounian
- Hiroyuki Kanao
- Naoko Komura
- Shinya Matsuzaki
- Lynda D. Roman
- Hadi Erfani
- Koji Matsuo
Institutions
- University of Southern California (US)
- Osaka City University (JP)
- Los Angeles Medical Center (US)
- The Cancer Institute Hospital (JP)
- Osaka International Cancer Institute (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- JAMA Oncology
- Published
- 2026-03-12
- DOI
- https://doi.org/10.1001/jamaoncol.2026.0170
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00